BIOAGE LABS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.87
-1.18%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-13.8%
3 months
-45.5%
6 months
-65.0%
1 year
-24.1%
Year to date
-55.6%
52-week range
$4.84 – $25.10
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$269.4M
P/E
-2.9
P/B
0.7
P/S
26
Revenue
$10.36M
Net income
-$94.46M
Diluted EPS
-2.38
Gross margin
100.00%
Net margin
-912.30%
Return on equity
-29.00%
Total debt
$2.84M
Cash
$73.96M
Free cash flow
-$88.09M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $2.45M | -$26.1M | 100.00% | -1064.70% | -$19.59M |
| Mar 31, 2026 | $2.77M | -$22.25M | 100.00% | -802.80% | -$24.07M |
| Dec 31, 2025 | $3.08M | -$25.94M | 100.00% | -842.90% | -$28.36M |
| Sep 30, 2025 | $2.05M | -$20.17M | 100.00% | -982.00% | -$16.07M |
| Jun 30, 2025 | $2.41M | -$21.56M | 100.00% | -894.00% | -$20.13M |
| Mar 31, 2025 | $1.45M | -$12.93M | 100.00% | -891.00% | -$17.79M |
| Dec 31, 2024 | $0 | -$21.13M | — | — | -$5.16M |
| Sep 30, 2024 | $0 | -$23.41M | — | — | -$15.24M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent BIOA news
All market newsNo ticker-linked stories are in the current archive.